1,080 results match your criteria Canada communicable disease report = Releve des maladies transmissibles au Canada[Journal]


CPHLN recommendations for the laboratory detection of Shiga toxin-producing (O157 and non-O157).

Can Commun Dis Rep 2018 Nov 1;44(11):304-307. Epub 2018 Nov 1.

National Microbiology Laboratory, MB & ON.

Shiga toxin-producing (STEC) are important enteric pathogens responsible for sporadic cases and outbreaks of gastroenteritis. O157:H7/NM (STEC O157) are the most commonly known STEC serotypes but it is now increasingly apparent that non-O157 STEC serotypes have been underreported in the past because they were not part of routine screening in many front-line laboratories. The Canadian Public Health Laboratory Network (CPHLN) has identified the need for improved detection and surveillance of non-O157 STEC and has developed the following recommendations to assist in the decision-making process for clinical and reference microbiology laboratories. Read More

View Article

Download full-text PDF

Source
https://www.canada.ca/content/dam/phac-aspc/documents/servic
Publisher Site
http://dx.doi.org/10.14745/ccdr.v44i11a06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449107PMC
November 2018
2 Reads

Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017.

Can Commun Dis Rep 2018 Nov 1;44(11):297-304. Epub 2018 Nov 1.

Centre for Biosecurity, Public Health Agency of Canada, Ottawa, ON.

Background: Under Canada's and , the Public Health Agency of Canada (PHAC) is mandated with monitoring laboratory incident notifications through the Laboratory Incident Notification Canada (LINC) surveillance system. The year 2017 marks the second complete year of data.

Objective: To describe the laboratory exposure and laboratory-acquired infection incidents that occurred in Canada in 2017 by sector, human pathogens and toxins involved, number of affected persons, incident type and root causes. Read More

View Article

Download full-text PDF

Source
https://www.canada.ca/content/dam/phac-aspc/documents/servic
Publisher Site
http://dx.doi.org/10.14745/ccdr.v44i11a05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449110PMC
November 2018
1 Read

Tuberculosis drug resistance in Canada: 2017.

Can Commun Dis Rep 2018 Nov 1;44(11):290-296. Epub 2018 Nov 1.

Centre for Communicable Disease and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: Drug-resistant tuberculosis (TB) is a global public health issue. To monitor this in Canada, surveillance systems have been in place for the last 20 years.

Objective: To describe drug resistance patterns among TB isolates in Canada in 2017 by type of resistance as well as geographic location, demographic data and origin and to compare current data to those of the previous 10 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14745/ccdr.v44i11a04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449088PMC
November 2018

The National Advisory Committee on Infection Prevention and Control (NAC-IPC).

Can Commun Dis Rep 2018 Nov 1;44(11):283-289. Epub 2018 Nov 1.

University of Manitoba, Winnipeg, MB.

This paper describes the work of the National Advisory Committee on Infection Prevention and Control (NAC-IPC), previously Infection Prevention and Control Expert Working Group, a longstanding external advisory body that provides subject matter expertise and advice to the Public Health Agency of Canada (PHAC) on the prevention and control of infectious diseases in Canadian health care settings. Originally established by Health Canada as the Infection Control Guidelines Steering Committee in 1992, this advisory board has been providing expert advice on infection prevention and control (IPC) guideline development for over 25 years. The NAC-IPC provides advice to inform the development of comprehensive or concise guidelines, quick reference guides and interim guidelines (usually for emerging pathogens), working closely with PHAC's national Healthcare-Associated Infections (HAIs) surveillance programs for Canadian health care facilities. Read More

View Article

Download full-text PDF

Source
https://www.canada.ca/content/dam/phac-aspc/documents/servic
Publisher Site
http://dx.doi.org/10.14745/ccdr.v44i11a03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449104PMC
November 2018
1 Read

Something wicked this way comes: What health care providers need to know about .

Can Commun Dis Rep 2018 Nov 1;44(11):271-276. Epub 2018 Nov 1.

Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB.

is a fungal pathogen that recently emerged and rapidly spread around the globe. It is now in Canada. can cause invasive disease with high mortality rates, is frequently resistant to one or more classes of antifungals, and can be difficult to identify in some clinical microbiology laboratories. Read More

View Article

Download full-text PDF

Source
https://www.canada.ca/content/dam/phac-aspc/documents/servic
Publisher Site
http://dx.doi.org/10.14745/ccdr.v44i11a01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449085PMC
November 2018
1 Read

HIV in Canada-Surveillance Report, 2017.

Can Commun Dis Rep 2018 Nov 6;44(12):348-356. Epub 2018 Dec 6.

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: Human immunodeficiency virus (HIV) is a global public health issue with an estimated 1.8 million people newly infected in 2017.

Objective: To provide a descriptive overview of reported cases of HIV in Canada by geographic location, sex, age group, exposure category and race/ethnicity, from 1985-2017, with a focus on the most recent data. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14745/ccdr.v44i12a03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390815PMC
November 2018

Advancing knowledge and increasing capacity to address climate-driven infectious diseases in Canada.

Can Commun Dis Rep 2018 Sep 4;44(10):267-270. Epub 2018 Oct 4.

Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.

The (PCF) was adopted in December 2016. This collaboratively developed federal, provincial and territorial report documents Canada's plans to meet its Paris Agreement commitments and stimulate Canada's economy. This PCF identifies a series of actions that will be addressed through four key pillars: pricing carbon pollution; complementary measures to reduce emissions; adaptation and climate resilience; and enabling economic growth through clean technology, innovation and jobs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14745/ccdr.v44i10a06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390814PMC
September 2018

Outbreak of Seoul virus among rats and rat owners - United States and Canada, 2017.

Can Commun Dis Rep 2018 Feb 1;44(2):71-74. Epub 2018 Feb 1.

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

What Is Already Known About This Topic?: Seoul virus, a type of hantavirus, is carried by Norway rats. Humans become infected through contact with virus shed in rat urine or droppings, or inhalation of virus particles in dust from contaminated bedding. Infected rats do not develop disease, but humans can experience symptoms ranging from mild influenza-like illness to severe disease with kidney failure and death. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864277PMC
February 2018

Rolling out HIV antiretroviral therapy in sub-Saharan Africa: 2003-2017.

Authors:
G Taylor

Can Commun Dis Rep 2018 Feb 1;44(2):68-70. Epub 2018 Feb 1.

Department of Medicine, University of Alberta, Edmonton, AB.

Multiple issues need to be addressed in order to control the HIV pandemic in sub-Saharan Africa. Combination antiretroviral therapy (cART) is key to reducing morbidity and mortality among people living with HIV and has a role in preventing HIV transmission. However, access to cART is very unevenly distributed globally, especially in sub-Saharan Africa. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864409PMC
February 2018
1 Read

Resources to address stigma related to sexuality, substance use and sexually transmitted and blood-borne infections.

Authors:
R MacLean

Can Commun Dis Rep 2018 Feb 1;44(2):62-67. Epub 2018 Feb 1.

Canadian Public Health Association, Ottawa, ON.

Background: Stigma is widely recognized as a significant barrier to the prevention, management and treatment of sexually transmitted and blood-borne infections (STBBIs) in Canada. Despite major advances in STBBI prevention and treatment, and global efforts to reduce stigma, people living with or affected by STBBIs continue to experience stigma within health and social service settings in Canada.

Objective: To describe the development, content and evaluation of knowledge translation resources and training workshops designed to equip health and social service professionals with the knowledge and skills needed to provide more respectful and inclusive sexual health, harm reduction and STBBI services. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864309PMC
February 2018
3 Reads

Lymphogranuloma venereum in Quebec: Re-emergence among men who have sex with men.

Can Commun Dis Rep 2018 Feb 1;44(2):55-61. Epub 2018 Feb 1.

Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, QC.

Background: Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) caused by genotypes L, L and L. This LGV is associated with significant morbidity and increased risk of HIV transmission. While fewer than two cases per year were reported in Quebec before 2005, LGV emerged in 2005-2006 with 69 cases, followed by a period of low incidence (2007-2012), and subsequent re-emergence since 2013. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864252PMC
February 2018
2 Reads

Chlamydia in Canada, 2010-2015.

Can Commun Dis Rep 2018 Feb 1;44(2):49-54. Epub 2018 Feb 1.

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: Chlamydia is the most commonly reported notifiable sexually transmitted infection in Canada. Rates have been steadily increasing since 1997.

Objective: To summarize trends in chlamydia rates for the period 2010-2015 in Canada. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864312PMC
February 2018
1 Read

Infectious and congenital syphilis in Canada, 2010-2015.

Can Commun Dis Rep 2018 Feb 1;44(2):43-48. Epub 2018 Feb 1.

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: Syphilis is the third most commonly reported notifiable sexually transmitted infection (STI) in Canada, following chlamydia and gonorrhea, respectively. Rates of this STI have been rising rapidly in Canada since 2001.

Objective: To summarize trends observed in syphilis rates for 2010 to 2015 in Canada. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864261PMC
February 2018
38 Reads

Gonorrhea in Canada, 2010-2015.

Can Commun Dis Rep 2018 Feb 1;44(2):37-42. Epub 2018 Feb 1.

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: Gonorrhea is the second most commonly reported sexually transmitted infection (STI) in Canada after chlamydia, and rates for this STI have been increasing since 1997.

Objective: To summarize trends observed in gonorrhea rates for 2010-2015 in Canada.

Methods: Laboratory-confirmed cases of gonorrhea are reported to the Public Health Agency of Canada (PHAC) by all of the Canadian provinces and territories. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933854PMC
February 2018

Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, species and .

Can Commun Dis Rep 2018 Jan 4;44(1):29-34. Epub 2018 Jan 4.

National Microbiology Laboratory, Winnipeg, MB.

The goal of this document was to provide Canadian laboratories with a framework for consistent reporting and monitoring of multidrug resistant organisms (MDRO) and extensively drug resistant organisms (XDRO) for common gram-negative pathogens. This is the final edition of the interim recommendations, which were modified after one year of broad consultative review. This edition represents a consensus of peer-reviewed information and was co-authored by the Canadian Public Health Laboratory Network and the Canadian Association of Clinical Microbiology and Infectious Diseases. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937062PMC
January 2018
2 Reads

Zika virus: Where to from here?

Authors:
P K Muchaal

Can Commun Dis Rep 2018 Jan 4;44(1):27-28. Epub 2018 Jan 4.

Centre for Food-borne and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON.

After the waves of reported cases of infection with Zika virus swept across the Americas in 2015-16, the overall transmission of the virus in the Western Hemisphere declined in 2017. Between June 8 and August 31, 2017, only 16 new cases of Zika virus infection, all travel-related, were reported in Canada. This represents an 88% reduction in the cases recorded during the same time frame in 2016. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937064PMC
January 2018
20 Reads

Travel-related Zika virus cases in Canada: October 2015-June 2017.

Can Commun Dis Rep 2018 Jan 4;44(1):18-26. Epub 2018 Jan 4.

Centre for Food-borne, Environmental and Zoonotic Infectious Diseases (CFEZID), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, ON.

Background: Zika virus (ZIKV) is an emerging mosquito-borne disease that can cause severe birth defects if contracted congenitally. Since late 2015, there has been a large increase in the number of travel-related cases of Zika virus infection in Canada.

Objective: The objective of this study was to describe the epidemiology of travel-related Zika cases in Canada from October 2015 to June 2017 and review them in the context of the international outbreak in the Americas. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937072PMC
January 2018
4 Reads

Canada's Pandemic Influenza Preparedness: Surveillance strategy.

Authors:
B Henry

Can Commun Dis Rep 2018 Jan 4;44(1):14-17. Epub 2018 Jan 4.

CPIP Task Group Chair.

The (CPIP) is a guidance document that outlines key health sector preparedness activities designed to ensure Canada is ready to respond to the next influenza pandemic. This article outlines Canada's pandemic influenza surveillance strategy as described in the CPIP . The strategy builds on the surveillance activities used for seasonal influenza and incorporates lessons learned from the 2009 H1N1 pandemic, including improved information sharing, improved electronic links among federal, provincial and territorial (FPT) partners and improved surveillance for Indigenous communities. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937067PMC
January 2018

Canada's Pandemic Influenza Preparedness: Laboratory strategy.

Authors:
B Henry

Can Commun Dis Rep 2018 Jan 4;44(1):10-13. Epub 2018 Jan 4.

CPIP Task Group Chair.

The (CPIP) is a guidance document that outlines key health sector preparedness activities designed to ensure Canada is ready to respond to the next influenza pandemic. This article outlines Canada's pandemic influenza laboratory strategy as described in the CPIP . Laboratory identification and characterization of an influenza pandemic virus is critical to detect the pandemic, develop a vaccine, detect antiviral resistance and inform surveillance functions such as monitoring the geographic spread of the disease. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937066PMC
January 2018

Canadian Pandemic Influenza Preparedness: Health sector planning guidance.

Authors:
B Henry

Can Commun Dis Rep 2018 Jan 4;44(1):6-9. Epub 2018 Jan 4.

CPIP Task Group Chair.

Pandemic preparedness requires a multifaceted approach with collaboration from all levels of government. The (CPIP) is a guidance document that outlines key health sector preparedness activities designed to ensure Canada is ready to respond to the next influenza pandemic. This article outlines Canada's approach to pandemic influenza preparedness as described in the CPIP Main Body. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937063PMC
January 2018
1 Read

Federal, provincial and territorial public health response plan for biological events.

Can Commun Dis Rep 2018 Jan 4;44(1):1-5. Epub 2018 Jan 4.

Centre for Emergency Preparedness and Response, Public Health Agency of Canada, Ottawa, ON.

The was developed for the Public Health Network Council (PHNC). This plan outlines how the national response to public health events caused by biological agents will be conducted and coordinated, with a focus on implementation of responses led by senior-level FPT public health decision-makers. The plan was developed by an expert task group and was approved by PHNC in October, 2017. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937070PMC
January 2018

Thompson outbreak associated with consumption of chicken shawarma and the usefulness of genome sequencing in the investigation.

Can Commun Dis Rep 2017 Sep 7;43(9):186-192. Epub 2017 Sep 7.

Laboratoire de Santé Publique du Québec, Sainte-Anne de Bellevue, QC.

Background: A sudden increase in Thompson (. Thompson) cases distributed throughout three border regions in the province of Quebec in November 2016 triggered a provincial investigation to identify a common source of contamination and to put the appropriate control measures into place.

Objective: To report on the outbreak and to describe the use of genomic sequencing to identify the salmonella serotype responsible. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864254PMC
September 2017
4 Reads

A reporting guide for Surveys.

Authors:

Can Commun Dis Rep 2017 Sep 7;43(9):184-185. Epub 2017 Sep 7.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764742PMC
September 2017

A reporting guide for Rapid Communications.

Authors:

Can Commun Dis Rep 2017 Sep 7;43(9):182-183. Epub 2017 Sep 7.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764721PMC
September 2017

Critical Appraisal Toolkit (CAT) for assessing multiple types of evidence.

Can Commun Dis Rep 2017 Sep 7;43(9):176-181. Epub 2017 Sep 7.

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Healthcare professionals are often expected to critically appraise research evidence in order to make recommendations for practice and policy development. Here we describe the Critical Appraisal Toolkit (CAT) currently used by the Public Health Agency of Canada. The CAT consists of: algorithms to identify the type of study design, three separate tools (for appraisal of analytic studies, descriptive studies and literature reviews), additional tools to support the appraisal process, and guidance for summarizing evidence and drawing conclusions about a body of evidence. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764727PMC
September 2017

A guide to publishing scientific research in the health sciences.

Authors:
P Huston Bck Choi

Can Commun Dis Rep 2017 Sep 7;43(9):169-175. Epub 2017 Sep 7.

School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON.

Effective communication of scientific research is critical to advancing science and optimizing the impact of one's professional work. This article provides a guide on preparing scientific manuscripts for publication in the health sciences. It is geared to health professionals who are starting to report their findings in peer-reviewed journals or who would like to refresh their knowledge in this area. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764717PMC
September 2017

Canada's pandemic vaccine strategy.

Can Commun Dis Rep 2017 Jul 6;43(7-8):164-167. Epub 2017 Jul 6.

Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.

The Public Health Agency of Canada has a mandate to prepare and respond to public health events, including influenza pandemics. Pandemic preparedness requires a multifaceted approach with collaboration from all levels of government. The (CPIP) is a guidance document that outlines key health sector preparedness activities designed to ensure Canada is ready to respond to the next influenza pandemic. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764724PMC

An outbreak of Shiga toxin-producing O121 infections associated with flour-Canada, 2016-2017.

Can Commun Dis Rep 2017 Jul 6;43(7-8):154-155. Epub 2017 Jul 6.

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

As of May 23, 2017, 29 cases of a new O121 infection have been identified in six provinces (Alberta, British Columbia, Newfoundland and Labrador, Ontario, Quebec and Saskatchewan) linked with the consumption of uncooked flour. One additional case was identified in a U.S. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864315PMC

First reported case of multidrug-resistant in Canada.

Can Commun Dis Rep 2017 Jul 6;43(7-8):150-153. Epub 2017 Jul 6.

Section of Infectious Diseases, Departments of Internal Medicine and Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB.

is a fungal pathogen that has recently emerged as a global threat to public health. It was first described in Japan in 2009 and has since been reported in 17 countries on five continents. This case report describes the first reported case of multidrug-resistant in Canada. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764715PMC

Increase in serogroup W invasive disease in Canada: 2009-2016.

Can Commun Dis Rep 2017 Jul 6;43(7-8):144-149. Epub 2017 Jul 6.

Provincial Public Health Laboratory, Eastern Health Microbiology Services, St. John's, NL.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764745PMC

Public health surveillance for the Toronto 2015 Pan/Parapan American Games.

Can Commun Dis Rep 2017 Jul 6;43(7):156-163. Epub 2017 Jul 6.

Public Health Ontario, Toronto, ON.

Background: Public health surveillance for previous Olympic and Paralympic Games have been described in the literature, but surveillance for regional, multisport events on a smaller scale have rarely been explored.

Objective: To describe the public health surveillance planning, implementation, results, and lessons learned from the 2015 Pan/Parapan American Games in Toronto, Ontario, Canada.

Intervention: Public health surveillance planning for the Games began two years in advance and involved local, provincial and federal partners, primarily focusing on infectious disease. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764728PMC

Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations.

Can Commun Dis Rep 2017 Jun 1;43(6):138-142. Epub 2017 Jun 1.

Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.

Background: Human papillomavirus (HPV) infections are the most common sexually transmitted infections. In the absence of vaccination, it is estimated that 75% of sexually active Canadians will have an HPV infection at some point in their lives. HPV vaccine programs were first recommended by Canada's National Advisory Committee on Immunization (NACI) in 2007. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864259PMC
June 2017
2 Reads

Evaluating the timeliness of reporting in a First Nations communicable diseases program.

Can Commun Dis Rep 2017 Jun 1;43(6):133-137. Epub 2017 Jun 1.

Northern Inter-Tribal Health Authority, Prince Albert, SK.

Background: Timely reporting of communicable diseases is necessary to enable a prompt response to mitigate and control outbreaks. This is especially true among First Nations communities due to a number of factors, including unique social determinants of health, which can contribute to rapid disease transmission.

Objective: To assess the timeliness of reporting for 12 notifiable communicable diseases in the Northern Inter-Tribal Health Authority, which includes 33 First Nations on-reserve communities in Northern Saskatchewan, Canada, and to assess whether there were differences in reporting times depending on degree of remoteness of community, season or year. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764711PMC
June 2017
3 Reads

Outbreaks in the age of syndemics: New insights for improving Indigenous health.

Authors:
A Andermann

Can Commun Dis Rep 2017 Jun 1;43(6):125-132. Epub 2017 Jun 1.

First Nations and Inuit Health Branch, Health Canada, Montréal, QC.

Conventional approaches for the prevention and control of communicable diseases within Indigenous contexts may benefit from new insights arising from the growing interest in syndemics. Syndemics is a term used to describe a conceptual framework for understanding diseases or health conditions, and how these are exacerbated by the social, economic, environmental and political milieu in which a population is immersed. The use of conventional approaches for outbreak prevention and control remains the bedrock of intervention in the field of communicable diseases; yet on their own, these strategies are not always successful, especially within contexts of marginalization and disadvantage. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764735PMC
June 2017
2 Reads

The use of technology to improve health care to Saskatchewan's First Nations communities.

Can Commun Dis Rep 2017 Jun 1;43(6):120-124. Epub 2017 Jun 1.

Department of Surgery, Royal University Hospital, Saskatoon, SK.

Background: Saskatchewan is a province of over one million people and over 13% are Indigenous peoples, many of whom live on reserve lands. Despite continued efforts, access to health care remains a significant challenge for these Indigenous people, especially those in the North.

Objective: To address this challenge, Saskatchewan's health care providers have been incorporating the use of technology for various health services. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764719PMC
June 2017
2 Reads

Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010-2014.

Can Commun Dis Rep 2017 May 4;43(5):114-118. Epub 2017 May 4.

Peel Public Health, Mississauga, ON.

Background: In Canada, identification and treatment of individuals with latent tuberculosis infection (LTBI) is a key component in preventing the progression of LTBI to active tuberculosis (TB). In Peel region, a large municipality in Ontario where half of the population is foreign-born, LTBI surveillance data are also critical to understanding the local epidemiology of TB.

Objective: To evaluate LTBI surveillance data collected through the integrated Public Health Information System (iPHIS) from 2010 to 2014 by assessing data quality and usefulness and to provide recommendations to improve surveillance for Peel region. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764718PMC
May 2017
1 Read

infections in post-operative patients exposed to heater-cooler devices: An overview.

Can Commun Dis Rep 2017 May 4;43(5):107-113. Epub 2017 May 4.

Department of Health, Government of New Brunswick, Fredericton, NB.

A multi-country outbreak of infection associated with contaminated heater-cooler devices (HCDs) has been reported, with more than 70 cases in Europe and the United States and two cases in Canada to date. The epidemiological and microbiological characteristics of this outbreak provide evidence for common-source transmission of from the exhaust air of intrinsically contaminated HCDs to patients during cardiac surgery. To date, all reported cases have been associated with Stöckert 3T HCDs manufactured at one plant by LivaNova prior to September 2014. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764710PMC
May 2017
1 Read

Summary of the NACI Update on the Recommended Use of Hepatitis B Vaccine.

Authors:
B Henry O Baclic

Can Commun Dis Rep 2017 May 4;43(5):104-106. Epub 2017 May 4.

Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.

Background: Infant and adolescent hepatitis B (HB) immunization programs have been successfully implemented in all Canadian provinces and territories since the 1990s. Following the introduction of universal immunization programs, the incidence of HB has decreased in all age groups. However, the duration of protection against chronic infection, as measured by preserved T- and B-cell memory, remains unknown. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864278PMC
May 2017
1 Read

Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017-2018.

Can Commun Dis Rep 2017 May 4;43(5):96-103. Epub 2017 May 4.

Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.

Background: Influenza is a respiratory infection caused primarily by influenza A and B viruses. Vaccination is the most effective way to prevent influenza and its complications. The National Advisory Committee on Immunization (NACI) provides recommendations regarding seasonal influenza vaccines annually to the Public Health Agency of Canada (PHAC). Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764726PMC
May 2017
2 Reads

Developing a vaccine for serotype a: Proceedings of a workshop.

Can Commun Dis Rep 2017 May 4;43(5):89-95. Epub 2017 May 4.

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Since the late 1990s there has been an emergence of serotype a (Hia) infections, especially in Indigenous communities in the northern regions of Canada and Alaska associated with significant morbidity and approximately a 10% mortality. A Hia vaccine could potentially prevent this disease and save the health care system millions of dollars in both acute and long-term care. On March 23-24, 2016, the National Research Council (NRC), the Public Health Agency of Canada (PHAC) and the Canadian Institutes of Health Research (CIHR) co-organized a meeting on serotype a (Hia) to examine the current state of disease epidemiology and a potential vaccine solution path. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764720PMC
May 2017
1 Read

The emerging serotype a infection and a potential vaccine: Implementation science in action.

Can Commun Dis Rep 2017 May 4;43(5):85-88. Epub 2017 May 4.

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

serotype b (Hib) was a major cause of meningitis in children until Hib conjugate vaccine was introduced into the routine infant immunization program and Hib disease in children was almost eliminated. In Alaska, northern Canada and other countries with Indigenous peoples, serotype a (Hia) has emerged as a significant cause of pneumonia, meningitis and septic arthritis especially in children under 24 months of age. A joint government initiative between the Public Health Agency of Canada (PHAC) and the National Research Council of Canada (NRC) was carried out to assess whether an Hia vaccine could be developed for the common good. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864301PMC
May 2017
1 Read

Canadian Public Health Laboratory Network position statement: Non-culture based diagnostics for gastroenteritis and implications for public health investigations.

Can Commun Dis Rep 2017 Dec 7;43(12):279-281. Epub 2017 Dec 7.

Provincial Public Health Laboratory, Eastern Health Microbiology Services, St. John's, NL.

As clinical laboratories transition to using culture-independent detection test (CIDT) panels for cases of acute gastroenteritis, culture of clinical specimens is becoming less common. The reduction in bacterial cultures available for public health activities is expected to hinder surveillance and outbreak response by public health laboratories at the local, provincial, national and international levels. These recommendations are intended to serve as guidelines for the implementation of CIDT panels in frontline laboratories in Canada. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764713PMC
December 2017
1 Read

Setting the stage for expanding HIV pre-exposure prophylaxis use in Canada.

Authors:
M Hull Dhs Tan

Can Commun Dis Rep 2017 Dec 7;43(12):272-278. Epub 2017 Dec 7.

Faculty of Medicine, University of Toronto, TorontoON.

Human immunodeficiency virus (HIV) infection continues to disproportionately affect vulnerable populations in Canada; particularly men who have sex with men (MSM). Novel HIV prevention strategies have recently expanded from the use of non-occupational post-exposure prophylaxis (nPEP) after high risk exposures to the use of pre-exposure prophylaxis (PrEP) in which individuals reduce risk of HIV infection through use of combination antiretrovirals taken prior to risk exposure. With approval of tenofovir/emtricitabine (TDF/FTC) for use as PrEP only in early 2016, and with limited public funding to date, uptake in Canada is in its preliminary stages. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937069PMC
December 2017
2 Reads

Assessing uptake of national HIV screening and testing guidance-Part 2: Knowledge, comfort and practice.

Can Commun Dis Rep 2017 Dec 7;43(12):267-271. Epub 2017 Dec 7.

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: The Public Health Agency of Canada's (PHAC) (the Guide) provides guidance to health care providers regarding who, when and how often to screen for HIV. HIV screening and testing is important in meeting the Joint United Nations Programme on HIV/AIDS' (UNAIDS) 90-90-90 targets towards HIV elimination.

Objective: To determine health care providers' levels of knowledge about and comfort with aspects of HIV testing, and to determine whether their HIV testing practices are consistent with the recommendations in the Guide. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764737PMC
December 2017

Assessing uptake of national HIV screening and testing guidance-Part 1: Awareness, use and usefulness.

Can Commun Dis Rep 2017 Dec 7;43(12):262-266. Epub 2017 Dec 7.

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: In 2013, the Public Health Agency of Canada released the (the Guide) to support routine HIV screening and testing practices of health care providers in Canada and promote early detection of new HIV cases. Little was known regarding health care providers' awareness and use of the Guide.

Objective: To determine Canadian health care providers' awareness, use and perceived usefulness of the Guide. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764712PMC
December 2017

AIDS in Canada-Surveillance Report, 2016.

Can Commun Dis Rep 2017 Dec 7;43(12):257-261. Epub 2017 Dec 7.

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: Although there continues to be a global epidemic of people living with human immunodeficiency virus (HIV) there has been a decrease in the number of people dying of acquired immunodeficiency syndrome (AIDS), largely due to successful treatment with antiretroviral therapy.

Objective: To provide a descriptive overview of the reported cases of AIDS in Canada by identifying trends by geographic location, sex, age group and mortality. While the descriptive analysis focuses on the year 2016, results are presented for reported cases from the beginning of national AIDS surveillance in 1979. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764731PMC
December 2017
1 Read

HIV in Canada-Surveillance Report, 2016.

Can Commun Dis Rep 2017 Dec 7;43(12):248-256. Epub 2017 Dec 7.

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: Human immunodeficiency virus (HIV) continues to be a global public health concern, with 2.1 million people newly infected in 2015. Although many high-income countries have noted decreasing rates of HIV, between 2013 and 2015 Canada's rates had stabilized at 5. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764722PMC
December 2017
15 Reads

Hepatitis A virus infection associated with cannabis use.

Can Commun Dis Rep 2017 Nov 2;43(11):245-246. Epub 2017 Nov 2.

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

We identified a case of acute Hepatitis A virus (HAV) infection linked to cannabis use. The local Public Health department received report of a man in his mid-20s with a classic presentation of hepatitis - jaundice, abdominal pain, vomiting, general malaise, and dark urine - as well as elevated serum aminotransferase levels and a positive anti-HAV IgM. Upon questioning, he reported no contact with ill individuals, or travel outside his metropolitan area. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764743PMC
November 2017
3 Reads

New vaccine administration practice recommendations from the .

Can Commun Dis Rep 2017 Nov 2;43(11):242-244. Epub 2017 Nov 2.

Public Health Nursing, Health PEI, Charlottetown, PE.

Background: The (CIG) is published online by the Public Health Agency of Canada and summarizes guidance on vaccines for human use into a single resource. Chapters are reviewed and updated on a regular basis. Vaccine administration is a critical part of any immunization program. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764714PMC
November 2017

Tuberculosis drug resistance in Canada: 2006-2016.

Can Commun Dis Rep 2017 Nov 2;43(11):236-241. Epub 2017 Nov 2.

Centre for Communicable Disease and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Background: Drug-resistant strains of tuberculosis (TB) pose a serious threat to TB prevention and control efforts. The Canadian Tuberculosis Laboratory Surveillance System (CTBLSS) was created in 1998 to monitor emerging trends and patterns in TB drug resistance in Canada.

Objective: To present a descriptive overview of TB drug resistance data collected through the CTBLSS for the years 2006 to 2016 in Canada, with a focus on 2016. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764739PMC
November 2017
1 Read